DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Gujarat Themis Biosyn Limited — Alteration Of Capital and Fund Raising-XBRL

NSE 2d ago·28 Aug 2026, 5:34 pm

Gujarat Themis Biosyn

Gujarat Themis Biosyn Limited has informed stock exchanges about the allotment of securities, which is a key step in its capital alteration plan. This move is part of the company's strategy to raise fresh funds and adjust its capital structure. For investors, this development signals the company's intent to strengthen its financial position and potentially fund future growth initiatives.

The allotment of securities is a neutral corporate action that can impact the company's equity base. While it may dilute the value of existing shares, it also provides the company with additional capital to invest in its operations. Investors should monitor the purpose of the raised funds and the company's future performance to gauge the long-term impact of this capital alteration.